Tumor Microenvironment in Hepatocellular Carcinoma: Key Players for Immunotherapy

Hepatocellular carcinoma (HCC) remains a serious medical therapeutic challenge as conventional curative avenues such as surgery and chemotherapy only benefit for few patients with limited tumor burden. Immunotherapy achieves clinical progress in the treatment of this prevalent malignant disease by v...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Hai, Zhuo, Yunhui, Zhang, Xuemei, Li, Yuyao, Li, Yue, Duan, Xiangjuan, Shi, Jia, Xu, Chengbin, Gao, Yueqiu, Yu, Zhuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618253/
https://www.ncbi.nlm.nih.gov/pubmed/36320666
http://dx.doi.org/10.2147/JHC.S381764

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9618253/
https://www.ncbi.nlm.nih.gov/pubmed/36320666
http://dx.doi.org/10.2147/JHC.S381764

Ejemplares similares